Denali Therapeutics Showcases BBB Innovation at AAIC 2026
SOUTH SAN FRANCISCO, Calif. | July 9, 2026 Denali Therapeutics has announced that co-founder and Chief Executive Officer Ryan...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
SOUTH SAN FRANCISCO, Calif. | July 9, 2026 Denali Therapeutics has announced that co-founder and Chief Executive Officer Ryan...
SALT LAKE CITY | July 9, 2026 Sera Prognostics Inc., a leader in precision pregnancy diagnostics, has announced the...
SALT LAKE CITY, June 23, 2026 Sera Prognostics Inc. welcomed new legislative action in Illinois that expands Medicaid coverage...
Stanford, California, January 21, 2026 — Researchers at Stanford University announced in January 2026 the development of a machine-learning...
